genprowebdirectory
Facebook
Linkedin
RSS
Twitter
Youtube
GEN Edge
Featured News
Multimedia
News
Insights
Topics
Artificial Intelligence
Bioprocessing
Cancer
Drug Discovery
Genome Editing
Infectious Diseases
OMICs
Translational Medicine
Magazine
Browse Issues
Subscribe
Multimedia
Summits
Webinars
GEN Live
Learning Labs
Podcasts
Resources
A-Lists
eBooks/Perspectives
Tutorials
Peer-Reviewed Journals
GEN Biotechnology
Re:Gen Open
New Products
Conference Calendar
Subscribe
Get GEN Magazine
Get GEN eNewsletters
Search
Facebook
Linkedin
RSS
Twitter
Youtube
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Privacy Policy
Password recovery
Recover your password
your email
A password will be e-mailed to you.
GEN – Genetic Engineering and Biotechnology News
GEN Edge
Featured News
Multimedia
News
Insights
Topics
Artificial Intelligence
Bioprocessing
Cancer
Drug Discovery
Genome Editing
Infectious Diseases
OMICs
Translational Medicine
Magazine
Browse Issues
Subscribe
Multimedia
Summits
Webinars
GEN Live
Learning Labs
Podcasts
Resources
A-Lists
eBooks/Perspectives
Tutorials
Peer-Reviewed Journals
GEN Biotechnology
Re:Gen Open
New Products
Conference Calendar
Subscribe
Get GEN Magazine
Get GEN eNewsletters
Home
2008
Eli Lilly and Company
News
Aradigm Regains Inhaled Insulin Program from Novo Nordisk
News
Nanogen Spins Out Firm and Plans to Merge with The Elitech Group
News
Eli Lilly Signs On Noxxon in R&D Deal for Migraine Treatments
News
Juvaris’ JVRS-100 Seen as Possible Way to Fortify H5N1 Vaccine Stockpile
News
Eli Lilly Launches $150M Expansion in Singapore
News
PsychoGenics and Eli Lilly Form Neuropsychiatric Agreement
News
Eli Lilly Amends Acquisition Price for ICOS to $2.3B
1
...
7
8
9
Page 9 of 9
Scroll Up
Scroll Up
